| Literature DB >> 35790895 |
Yu-Wei Liu1,2,3, Chieh-Ni Kao1, Hung-Hsing Chiang1,3, Jui-Ying Lee1, Hsien-Pin Li1, Po-Chih Chang1,2, Shah-Hwa Chou1,2.
Abstract
BACKGROUND: Completion lobectomy (CL) after anatomical segmentectomy is technically challenging and rarely performed. Here, we aimed to report perioperative outcomes of a single center real-world CL data.Entities:
Keywords: completion lobectomy; lung cancer; perioperative outcome; segmentectomy
Mesh:
Year: 2022 PMID: 35790895 PMCID: PMC9376176 DOI: 10.1111/1759-7714.14565
Source DB: PubMed Journal: Thorac Cancer ISSN: 1759-7706 Impact factor: 3.223
FIGURE 1Flow diagram of patient recruitment
Demographic data of patients who underwent a previous segmentectomy
| No (age/gender) | FEV1 (Pred) before segmentectomy, liter (%) | FEV1 (Pred) before CL, liter (%) | Previous segmentectomy | MLD | Surgical approach | Feature of the targeted nodule | Diagnosis of segmentectomy | Surgical margin | Use of PGA sheet | Use of fibrin glue |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 (72/male) | 1.98 (87%) | 1.66 (82%) | RS | Yes | VATS | Solid, 1.8 cm | Metastatic cancer | R0 | Yes | No |
| 2 (71/male) | 2.72 (97%) | 2.68 (94%) | RS9+10 | Yes | VATS | Part‐solid, 1.5 cm | Lung cancer | R0 | Yes | No |
| 3 (24/female) | 3.53 (107%) | 3.2 (99%) | RS | Yes | VATS | GGO, 1.0 cm | Lung cancer | R0 | Yes | No |
| 4 (56/female) | 2.25 (105%) | 2.1 (107%) | RS | Yes | VATS | GGO, 0.6 cm | Inflammation | R0 | No | No |
| 5 (68/female) | 1.3 (72%) | 1.39 (77%) | RS | Yes | VATS | Solid, 1.2 cm | Metastatic cancer | R0 | Yes | No |
| 6 (77/female) | 1.41 (80%) | 1.31 (94%) | RS6 | Yes | VATS | Solid, 2 cm | Lung cancer | R0 | Yes | No |
| 7 (47/male) | 3.43 (103%) | 3.10 (93%) | RS7+8 | Yes | VATS | GGO, 0.6 cm | Lung cancer | R0 | Yes | No |
Abbreviations: FEV1 (Pred), forced expiratory volume in the first second of expiration (predicted %), CL, completion lobectomy; MLD, mediastinal lymph node dissection; PGA, polyglycolic acid; RS, right pulmonary segment; VATS, video‐assisted thoracic surgery; GGO, ground‐glass opacity.
Perioperative data of patients who underwent complete lobectomy
| No | ASA score | Reason for CL | Lobe for CL | Diagnosis after CL | Interval to CL (weeks) | Surgical approach | Operative time (min) | Blood loss (ml) | Degree of adhesions | PA taping | Perioperative complication | Postoperative stay (days) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 3 | Staple line recurrence | RUL | Metastatic cancer | 180 | Thoracotomy | 340 | 700 | Severe | Yes | Azygos vein injury, PAL | 9 |
| 2 | 3 | Staple line recurrence | RLL | Hemangioma | 57 | Thoracotomy | 320 | 200 | Severe | No | Diaphragm injury | 6 |
| 3 | 2 | Remaining lobe atelectasis | RML | Granuloma | 5 | VATS | 160 | 120 | Mild | No | No | 7 |
| 4 | 2 | Staple line recurrence | RLL | Organized pneumonia | 120 | VATS | 180 | 100 | Mild | No | No | 6 |
| 5 | 3 | Remaining lobe and staple line recurrence | RUL | Metastatic cancer | 50 | Thoracotomy | 350 | 400 | Severe | No | PAL | 10 |
| 6 | 3 | Remaining lobe and staple line recurrence | RLL | Lung cancer | 52 | Thoracotomy | 250 | 200 | Severe | No | PAL | 9 |
| 7 | 2 | Short surgical margin | RLL | granuloma | 9 | VATS | 340 | 470 | Severe | No | No | 5 |
Abbreviations: ASA, American Society of Anesthesiologists; CL, completion lobectomy; PA, pulmonary artery; RUL, right upper lobe; RLL, right lower lobe; RML, right middle lobe; MC, metastatic cancer; PAL, prolonged air leakage; VATS, video‐assisted thoracic surgery.
FIGURE 2Computed tomography (CT) of the representative case who underwent completion lobectomy of the RUL after a right VATS S3 segmentectomy. (a) CT imaging revealed two nodules in right pulmonary segment 3. (b) Three‐dimensional reconstruction imaging revealed the relative location between targeted nodules and bronchovascular structures of segment 3. (c) CT scan showing recurrent nodule abutting previous staple lines at 50 weeks after right S3 segmentectomy. (d) CT scan demonstrated previous staple lines tightly attached to the medial mediastinum. RUL, right upper lobe; CT, computed tomography; VATS, video‐assisted thoracic surgery.
FIGURE 3Intraoperative view of the representative case who underwent completion lobectomy of the right upper lobe (RUL) after a right VATS S3 segmentectomy. (a) Right lateral mini‐thoracotomy incision (12 cm). (b) Pneumolysis for the dense adhesions over posterior pleural cavity. (c) Pneumolysis for the dense adhesions over anterior pleural cavity. (d) Division of right upper lobe (RUL) bronchus. (e) Isolation and division of the right pulmonary artery 1. (f) Isolation and division of the right pulmonary artery 2. (g) Simultaneous stapling of RUL lung parenchyma and pulmonary vein using a stapler with black cartridge. (h) View of remaining hilar structure after completion lobectomy of RUL. RUL, right upper lobe; VATS, video‐assisted thoracic surgery.
Perioperative data of patients who underwent complete lobectomy
| First author | Year of publication | Age/gender | Reason for CL | Lobe of CL or previous segment | Interval to CL (weeks) | Surgical approach | Operative time (min) | Blood loss (ml) | Severe adhesions | PA taping | Perioperative complication | Postoperative stay (days) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Omasa [ | 2016 | 3 pts (N/A) | Complication | N/A | 0.8 | Thoracotomy | 95 | 57 | No | No | 5/11 (45%) | N/A |
| 3 pts (N/A) | LN metastasis | N/A | 4.9 | Thoracotomy | 274 | 410 | 3 | 1/3 (33%) | N/A | |||
| 5 pts (N/A) | Recurrence | N/A | 105 | Thoracotomy | 253 | 381 | 5 | 4/5 (80%) | N/A | |||
| Takahashi [ | 2019 | 66/M | Recurrence | LS6 | 72 | VATS | 295 | 500 | No (mild) | No | No | 9 |
| 70/F | Recurrence | RS7+10 | 208 | VATS | 389 | 200 | Yes | Yes | PA injury | 16 | ||
| 72/M | Recurrence | RS2 | 180 | VATS | 280 | 300 | Yes | No | No | 12 | ||
| 74/F | Recurrence | RS8+9 | 16 | VATS | 279 | 950 | No (mild) | No | No | 12 | ||
| 73/M | Recurrence | RS3 | 160 | VATS | 342 | 350 | Yes | No | Postoperative Af | 14 | ||
| 61/F | Recurrence | LS1+2+3 | 432 | Thoracotomy | 458 | 6870 | Yes | No | PA injury | 14 | ||
| 69/F | Recurrence | RS2 | 308 | Thoracotomy | 201 | 200 | Yes | No | Azygos vein injury | 8 | ||
| 64/M | Recurrence | LS1+2+3 | 8 | Thoracotomy | 339 | 1020 | Yes | Yes | No | 13 | ||
| 80/F | Recurrence | LS1+2 | 192 | Thoracotomy | 391 | 500 | Yes | No | PA injury | 18 | ||
| 65/M | Recurrence | LS9+10 | 84 | Thoracotomy | 301 | 160 | No (mild) | No | No | 8 | ||
| Suzuki [ | 2021 | 65/F | Recurrence | RS6 | 148 | Thoracotomy | 167 | 75 | No (mild) | No | No | 9 |
| 82/F | Recurrence | RS6 | 156 | Thoracotomy | 255 | 220 | No (mild) | No | No | 7 | ||
| 81/F | Recurrence | LS6 | 164 | Thoracotomy | 316 | 100 | No (mild) | No | No | 18 | ||
| 67/F | Recurrence | RS1 | 64 | Thoracotomy | 284 | 370 | Yes | No | PV injury | 21 | ||
| Takamori [ | 2021 | N/A | Second LC | LS1+2 | 306 | Thoracotomy | 194 | 543 | Yes | Yes | No | 10 |
| N/A | Second LC | RS3a | 98 | VATS | 234 | 61 | No (mild) | Yes | Arrhythmia | 5 | ||
| N/A | Pathological change | RS8a | 1 | VATS | 138 | 253 | No (mild) | No | No | 6 | ||
| N/A | Recurrence | RS10 | 109 | Thoracotomy | 165 | 230 | Yes | No | No | 5 | ||
| N/A | Pathological change | RS6 | 4 | Thoracotomy | 226 | 906 | Yes | Yes | PAL | 6 | ||
| N/A | Pathological change | LS9+10 | 19 | VATS | 216 | 206 | Yes | No | No | 6 | ||
| N/A | Second LC | RS8+6b | 120 | Thoracotomy | 175 | 248 | No (mild) | Yes | No | 8 | ||
| N/A | Second LC | LS1+2+3 | 133 | Thoracotomy | 407 | 2194 | Yes | No | No | 7 | ||
| Komatsu [ | 2021 | 20/M | Pathological change | LS8+9+10 | 2 | VATS | 266 | 200 | No (mild) | No | No | 13 |
Abbreviations: CL, completion lobectomy; PA, pulmonary artery; pts, patients; LN, lymph node; LC, lung cancer; RS, right pulmonary segment; LS, left pulmonary segment; PAL, prolonged air leakage; VATS, video‐assisted thoracic surgery; N/A, not available.
Summarized perioperative outcome based on surgical approach for patients undergoing completion lobectomy
| Variables | VATS ( | Thoracotomy ( |
|
|---|---|---|---|
| Targeted lobe for CL, n (%) | 0.32 | ||
| RUL | 3 (25) | 6 (20.7) | |
| RML | 1 (8.3) | 0 (0) | |
| RLL | 4 (33.4) | 11 (37.9) | |
| RML + RLL | 1 (8.3) | 0 (0) | |
| LUL | 0 (0) | 8 (27.6) | |
| LLL | 3 (25) | 4 (13.8) | |
| Targeted lobe for CL, n (%) | |||
| Upper lobe | 3 (25) | 14 (48) | 0.17 |
| Nonupper lobe | 9 (75) | 15 (52) | |
| Reasons for CL, n (%) | 0.28 | ||
| Complication | 5 (42) | 4 (14) | |
| Unexpected LN metastasis | 0 (0) | 3 (10) | |
| Local recurrence | 7 (58) | 22 (76) | |
| Interval to CL, week (IQR) | 45 (7–140) | 105 (7.2–150) | 0.58 |
| Operation time, min (IQR) | 272 (198–317) | 253 (199–317) | 0.89 |
| Estimated blood loss, ml (IQR) | 229 (160–410) | 381 (200–432) | 0.37 |
| Postoperative hospital stay, day (IQR) ( | 8 (6–12) | 9 (7–13) | 0.43 |
| Severe hilar adhesion, n (%) | 5 (42) | 21 (72) | 0.06 |
| PA taping, n (%) | 2 (17) | 10 (34) | 0.26 |
| Perioperative complication, n (%) | 3 (25) | 14 (48) | 0.29 |
, only 30 patients available for analysis (13 vs. 17, respectively).
Abbreviations: CL, completion lobectomy; RUL, right upper lobe; RML, right middle lobe; RLL, right lower lobe; LUL, left upper lobe; LLL, left lower lobe; LN, lymph node; VATS, video‐assisted thoracic surgery; IQR, interquartile range; PA, pulmonary artery.
Summarized perioperative outcome based on interval between segmentectomy and completion lobectomy
| Variables | Short (interval to CL ≤8 weeks) ( | Long (interval to CL >8 weeks) ( |
|
|---|---|---|---|
| Reasons for CL, n (%) | 0.0001 | ||
| Complication | 7 (64) | 2 (7) | |
| Unexpected LN metastasis | 3 (27) | 0 (0) | |
| Local recurrence | 1 (9) | 28 (93) | |
| Surgical approach with VATS, n (%) | 3 (27) | 9 (30) | 1.0 |
| Operation time, min (IQR) | 226 (105–274) | 267 (234–340) | 0.02 |
| Estimated blood loss, ml (IQR) | 253 (72–410) | 360 (200–470) | 0.55 |
| Postoperative hospital stay, day (IQR) ( | 7 (6–13) | 9 (6.7–12.5) | 0.63 |
| Severe hilar adhesion, n (%) | 5 (45) | 21 (70) | 0.15 |
| PA taping, n (%) | 3 (27) | 9 (30) | 1.00 |
| Perioperative complication, n (%) | 4 (36) | 13 (43) | 0.69 |
, only 30 patients available for analysis (5 vs. 25, respectively).
Abbreviations: CL, completion lobectomy; LN, lymph node; VATS, video‐assisted thoracic surgery; IQR, interquartile range; PA, pulmonary artery.